Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT01142232
Status:
COMPLETED
Last Update Posted:
2019-10-22
First Post:
2010-06-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
Sponsor:
Attaya Suvannasankha
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2015-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-10
First Submit QC Date:
None
Study First Post Date:
2010-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-17
Results First Submit QC Date:
None
Results First Post Date:
2019-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-03
Last Update Post Date:
2019-10-22
Last Update Post Date Type:
ACTUAL